SCHEMBL5548306

SCHEMBL5548306

Nc1ccccc1NC(=O)c1ccc(C(NC(=O)c2ccccc2)C(=O)Nc2cccc3ccccc23)cc1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 4/20 0.59
RAB9A P51151 4/20 0.59
CYP1A2 P05177 1/20 0.59
CYP3A4 P08684 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
CYP2C19 P33261 1/20 0.59
HDAC1 Q13547 14/20 0.54
HDAC2 Q92769 8/20 0.54
HDAC3 O15379 7/20 0.54
MAPK1 P28482 1/20 0.54
KMT2A Q03164 2/20 0.51
MEN1 O00255 1/20 0.51
NCOR2 Q9Y618 4/20 0.50
HDAC4 P56524 1/20 0.47
HDAC7 Q8WUI4 1/20 0.47
HDAC10 Q969S8 1/20 0.47
HDAC11 Q96DB2 1/20 0.47
HDAC8 Q9BY41 1/20 0.47
HDAC6 Q9UBN7 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2108538 0.85 HDAC1 (0.71) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL2686859 0.83 HDAC1 (0.57) NPC1RAB9AHDAC1HDAC2HDAC3
SCHEMBL2687141 0.81 HDAC1 (0.76) HDAC1HDAC2HDAC3MAPK1NCOR2
SCHEMBL2687023 0.80 HDAC1 (0.63) HDAC1HDAC2HDAC3MAPK1NCOR2
SCHEMBL2684952 0.80 HDAC1 (0.63) NPC1RAB9AHDAC1HDAC2HDAC3
SCHEMBL2686930 0.79 HDAC1 (0.67) NPC1RAB9AHDAC1HDAC2HDAC3
SCHEMBL30184438 0.77 NPC1 (1.00) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL4642544 0.77 NPC1 (1.00) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL28619493 0.76 KDM4E (0.62) NPC1RAB9ACYP1A2CYP3A4CYP2D6
SCHEMBL10528579 0.74 NPC1 (0.76) NPC1RAB9ACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1991226-B1 INHIBITORS OF HISTONE DEACETYLASE MERCK SHARP & DOHME (US) 2013-03-20 EP disclosed
US-8168658-B2 Inhibitors of histone deacetylase MERCK SHARP & DOHME CORP. (US) 2012-05-01 US disclosed
US-8168658-B2 Inhibitors of histone deacetylase MERCK SHARP & DOHME CORP. (US) 2012-05-01 US disclosed
US-20090069250-A1 Inhibitors of Histone Deacetylase MERCK SHARP & DOHME LLC 2009-03-12 US disclosed
US-20090069250-A1 Inhibitors of Histone Deacetylase MERCK SHARP & DOHME LLC 2009-03-12 US disclosed
WO-2007100657-A2 INHIBITORS OF HISTONE DEACETYLASE MERCK & CO., INC. (US) 2007-09-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090069250-A1 Inhibitors of Histone Deacetylase HDAC1, HDAC5, HDAC6 NPC1 3227/4885RAB9A 4368/4885CYP1A2 3636/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.